Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
Phase I Study to Evaluate the Safety of Dexibuprofen 300mg (Apsen Pharmaceuticals A / S.) After a Single and Multiple Dose Oral Administration in Healthy Participants of Both Sexes Under Fasting and Fed Conditions.
Epistemonikos ID: d4a08b4112c7829a96b0c08691421657286be357
First added on: May 17, 2024